2 completed, 1 terminated. 2 Phase 4, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Current ART: new trials by email Literature Review of Current ART trials Research Report on Current ART
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EFFICACY AND SAFETY OF A SIMPLIFICATION STRATEGY BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS OPTIMIZED TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS CARRYING ARCHIVED MULTIDRUG RESISTANCE MUTATIONS Dolutegravir (DTG) plus Darunavir/cobicistat (DRV/cobi)., Current ART - HIV-1 Infection | Phase 4 | Completed | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 96 | 2018-11-19 | 2022-04-01 |
| (mo)BETTA Trial in Transwomen for Optimization of ART B/FTC/TAF, Current ART - HIV Infections | Phase 4 | Terminated | The University of Texas Health Science Center, Houston | 26 | 2018-06-06 | 2022-10-03 |
| Clinical Trial to Evaluate the Effect of Raltegravir Intensification (1.200 mg QD) on the Gut Microbiota of Chronically HIV-1 Infected Subject Over Time: THE RAGTIME STUDY Raltegravir, Placebo, Current ART - HIV | Phase 3 | Completed | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 61 | 2017-07-28 | 2025-06-17 |
HIV Infections (2)
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia (2) · The University of Texas Health Science Center, Houston (1)
Spain (2) · United States (1)